Kendra Grubb, MD, one of the country's leading experts on cardiac surgery, discussed what she tells her patients when they ask if TAVR is better than SAVR for treating severe aortic stenosis. 

More than 100 U.S. medical societies are throwing their support behind a new proposal that could reform out-of-date Medicare policies and help limit future payment cuts. 

Lawrence Faucette, the second patient to ever receive a genetically modified pig heart, died on Oct. 30. “He can never be forgotten," his wife said in a statement. 

Michael Reardon, MD, discussed his team's late-breaking results at TCT 2023 in San Francisco. 

Even as TAVR continues to build momentum as the go-to treatment option for many patients, researchers are keeping a close eye on the long-term safety and effectiveness of SAVR.

Researchers explored data from the first 10 patients treated with a new self-expanding TAVR device from KOKA Lifesciences. After 30 days, there were no patient deaths and only one adverse event.

That same team that transplanted a pig heart into a human patient for the very first time in 2022 has now done it again. The patient is currently recovering from the procedure, which occurred on Sept. 20. 

The new ranking, based on extensive survey data gathered by Newsweek, includes a total of 150 hospitals. Seven of the top 10 are located in the United States.